Prof. Filip Van Nieuwerburgh is Professor at the Faculty of Pharmaceutical Sciences, Ghent University. He completed his PhD studies in Pharmaceutical Sciences at Ghent University and has received academic recognition for his research and service contributions. He undertook extended research stays abroad at the Scripps Research Institute, Center for Protein and Nucleic Acid Research, San Diego, USA, and held a sabbatical at the I3 Lab, Sorbonne University, Paris, France (February–November 2022). He has led and contributed to multiple national and international research projects and actively participates in numerous international scientific congresses. He acts as promotor of multiple master’s theses and PhD students and has published many papers in peer-reviewed journals. He serves as an expert in clinical statistics and pharmacokinetics for the EMA/CHMP and the Belgian Federal Agency for Medicines and Health Products (FAGG). He is an Editorial Board member of Nature Scientific Reports and a reviewer for A1 publications and funding agencies, including FWO, ITC Hong Kong, and INRA France. Since October 2022, he has been an elected representative of the professorial staff in the Faculty Council. He is a member of the ASHG and the International Society of Forensic Genetics. His teaching disciplines include bioinformatics, genomics, and data analysis, and his research interests include next-generation sequencing, (epi)genomics, transcriptomics, and forensics.
Prof. Filip Van Nieuwerburgh is Professor at the Faculty of Pharmaceutical Sciences, Ghent University. He completed his PhD studies in Pharmaceutical Sciences at Ghent University and has received academic recognition for his research and service contributions. He undertook extended research stays abroad at the Scripps Research Institute, Center for Protein and Nucleic Acid Research, San Diego, USA, and held a sabbatical at the I3 Lab, Sorbonne University, Paris, France (February–November 2022). He has led and contributed to multiple national and international research projects and actively participates in numerous international scientific congresses. He acts as promotor of multiple master’s theses and PhD students and has published many papers in peer-reviewed journals. He serves as an expert in clinical statistics and pharmacokinetics for the EMA/CHMP and the Belgian Federal Agency for Medicines and Health Products (FAGG). He is an Editorial Board member of Nature Scientific Reports and a reviewer for A1 publications and funding agencies, including FWO, ITC Hong Kong, and INRA France. Since October 2022, he has been an elected representative of the professorial staff in the Faculty Council. He is a member of the ASHG and the International Society of Forensic Genetics. His teaching disciplines include bioinformatics, genomics, and data analysis, and his research interests include next-generation sequencing, (epi)genomics, transcriptomics, and forensics.